Tackling stalled development productivity requires sharp decision making. Leading biopharma are replacing fragmented analysis with connected, causal decision systems to optimize speed, cost, and success rates.
Overcoming the R&D bottleneck: Building a causal decision system
calendar_today
October 31, 2026
domain
mckinsey-and-company